» Articles » PMID: 2729936

Influence of Antibiotic Dose, Dosing Interval, and Duration of Therapy on Outcome in Experimental Pneumococcal Meningitis in Rabbits

Overview
Specialty Pharmacology
Date 1989 Apr 1
PMID 2729936
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

We examined the influence of several pharmacokinetic parameters on cure rates in rabbits with experimental pneumococcal meningitis. When the duration of treatment was kept constant, cure rates improved as the individual dose of ampicillin was increased. On the other hand, when four doses of ampicillin at 60 mg/kg of body weight, producing peak concentrations in cerebrospinal fluid (CSF) of approximately 40 times the MBC, were administered at intervals of 24 instead of 4 h and the duration of therapy was thus prolonged from 12 to 72 h, cure rates also increased (85 versus 25%; P less than 0.01). These high cure rates were achieved even though bacterial titers in CSF 24 h after the first dose had reached levels similar to those present at the beginning of therapy. Cure in these animals was explained by the fact that the second ampicillin dose reduced bacterial titers in CSF significantly more than did the first dose (5.2 versus 2.5 log10 CFU/ml; P less than 0.02). The clinical relevance of these observations remains to be determined.

Citing Articles

Clinical pharmacokinetics of antibacterials in cerebrospinal fluid.

Di Paolo A, Gori G, Tascini C, Danesi R, Del Tacca M Clin Pharmacokinet. 2013; 52(7):511-42.

PMID: 23605634 DOI: 10.1007/s40262-013-0062-9.


Pharmacodynamics of vancomycin for the treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis.

Ahmed A, Jafri H, Lutsar I, McCoig C, Trujillo M, Wubbel L Antimicrob Agents Chemother. 1999; 43(4):876-81.

PMID: 10103194 PMC: 89220. DOI: 10.1128/AAC.43.4.876.


Evaluation of moxifloxacin, a new 8-methoxyquinolone, for treatment of meningitis caused by a penicillin-resistant pneumococcus in rabbits.

Ostergaard C, Sorensen T, Knudsen J, Frimodt-Moller N Antimicrob Agents Chemother. 1998; 42(7):1706-12.

PMID: 9661008 PMC: 105670. DOI: 10.1128/AAC.42.7.1706.


Pharmacodynamics and bactericidal activity of ceftriaxone therapy in experimental cephalosporin-resistant pneumococcal meningitis.

Lutsar I, Ahmed A, Friedland I, Trujillo M, Wubbel L, Olsen K Antimicrob Agents Chemother. 1997; 41(11):2414-7.

PMID: 9371342 PMC: 164137. DOI: 10.1128/AAC.41.11.2414.


Trovafloxacin in treatment of rabbits with experimental meningitis caused by high-level penicillin-resistant Streptococcus pneumoniae.

Kim Y, Liu Q, Chow L, Tauber M Antimicrob Agents Chemother. 1997; 41(5):1186-9.

PMID: 9145898 PMC: 163879. DOI: 10.1128/AAC.41.5.1186.


References
1.
Hodges G, Perkins R . Acute bacterial meningitis: an analysis of factors influencing prognosis. Am J Med Sci. 1975; 270(3):427-40. DOI: 10.1097/00000441-197511000-00003. View

2.
Sande M, Sande E, Woolwine J, Hackbarth C, Small P . The influence of fever on the development of experimental Streptococcus pneumoniae meningitis. J Infect Dis. 1987; 156(5):849-50. DOI: 10.1093/infdis/156.5.849. View

3.
Strausbaugh L, Sande M . Factors influencing the therapy of experimental Proteus mirabilis meningitis in rabbits. J Infect Dis. 1978; 137(3):251-60. DOI: 10.1093/infdis/137.3.251. View

4.
Sande M, Korzeniowski O, Allegro G, Brennan R, Zak O, Scheld W . Intermittent or continuous therapy of experimental meningitis due to Streptococcus pneumoniae in rabbits: preliminary observations on the postantibiotic effect in vivo. Rev Infect Dis. 1981; 3(1):98-109. DOI: 10.1093/clinids/3.1.98. View

5.
Mackowiak P, Cohen R . Effects of temperature on antimicrobial susceptibility of bacteria. J Infect Dis. 1982; 145(4):550-3. DOI: 10.1093/infdis/145.4.550. View